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Abstract
The physiological role of the respiratory hemoproteins (RH), hemoglobin and myoglobin, is to deliver O2 via its binding to
their ferrous (Fe
II) heme-iron. Under variety of pathological conditions RH proteins leak to blood plasma and oxidized to
ferric (Fe
III, met) forms becoming the source of oxidative vascular damage. However, recent studies have indicated that both
metRH and peroxides induce Heme Oxygenase (HO) enzyme producing carbon monoxide (CO). The gas has an extremely
high affinity for the ferrous heme-iron and is known to reduce ferric hemoproteins in the presence of suitable electron
donors. We hypothesized that under in vivo plasma conditions, peroxides at low concentration can assist the reduction of
metRH in presence of CO. The effect of CO on interaction of metRH with hydrophilic or hydrophobic peroxides was analyzed
by following Soret and visible light absorption changes in reaction mixtures. It was found that under anaerobic conditions
and low concentrations of RH and peroxides mimicking plasma conditions, peroxides served as electron donors and RH
were reduced to their ferrous carboxy forms. The reaction rates were dependent on CO as well as peroxide concentrations.
These results demonstrate that oxidative activity of acellular ferric RH and peroxides may be amended by CO turning on the
reducing potential of peroxides and facilitating the formation of redox-inactive carboxyRH. Our data suggest the possible
role of HO/CO in protection of vascular system from oxidative damage.
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Introduction
Hemoglobin (Hb) and myoglobin (Mb) are collectively known as
therespiratoryhemoproteins(RH)basedontheirfunctiontodeliver
molecularoxygentothebodytissues.Whilethelinkbetweenferrous
(Fe
II) heme-iron and molecular oxygen provides the essence of
aerobic metabolism, this molecular function is also vulnerable to
detrimental effects by auto-oxidation due to electron transfer from
the heme-iron to oxygen: Fe
II-O2RFe
III+O
?
2RH2O2 [1]. The
products of the reaction, ferric (Fe
III, met-) RH as well as active
oxygen species, are hazardous to the vascular system, as they can
induce pathological events, such as atherosclerosis. The ferric forms
of the RH bear peroxidase-like activity leading to the unstable,
potentially damaging ferryl (Fe
IV) state [2–5,6,7]. The ferryl forms
tend to undergo synproportionation in presence of ferrous, oxy-
forms to the more stable ferric forms (Fe
II+Fe
IVR2Fe
III) which is
longer-livedandhenceitslikelihoodtoprovidedamagearehigh[8].
Indeed, under a variety of oxidative pathological conditions, ferric
RH have been reported to be elevated in blood plasma [9–12].
The pathological redox interactions of metRH with hydrophilic
peroxides, i.e. H2O2, have been elucidated over the years and their
reaction mechanisms have been analyzed in detail on the
molecular level [2,13,14]. Interactions between the hydrophilic
hemoproteins and hydrophobic peroxides, mostly formed in cell
membranes and plasma lipoproteins, i.e. LDL, have been
documented as well [15–17]. A wealth of information regarding
the RH interactions with LDL, induced by both H2O2 and
hydrophobic peroxides within the LDL particles has been reported
[15,18,19]. Peroxides acquired their notorious reputation as
damaging oxidative agents, especially upon interaction with RH
[3]. It should be emphasized that damage by intact metRH forms
can be attenuated as long as the hemin is globin bound, namely
metRH function as intact heme-proteins. Slow irreversible
detachment of hemin from ferric RH occurs as well and its
hazardous activity is irreversible [15]. An evolutionary advantage
was gained by encapsulating the RH in erythrocytes or myocytes
which contain a collection of enzymes responsible for reducing any
ferric heme formed back to its ferrous state [20,21]. After multiple
trials, the tendency of cell-free hemoglobin to undergo undesired
oxidations has so far impeded efforts to use stabilized hemoglobin
solutions as blood substitutes [22]. It is important to note that
peroxides can also function as reducing agents [23]. In fact, in the
plant kingdom, peroxides are active as electron donors, namely as
reducing agents [24]. Interestingly, current studies have pointed
out that under certain conditions, cell-free hemoglobin also acts as
an antioxidant and protects different cell types from H2O2-
induced oxidative damage. It was thus proposed that complex
interactions determine whether Hb will act as a damaging or
protective agent under different circumstances, the mechanisms
behind this dual chemical nature are still obscure [25].
Although the RH function primarily as oxygen carriers, lately
attention has been focused on their role as physiological carriers of
two other gas ligand molecules, nitric oxide (NO), which binds to
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which binds with extremely high affinity exclusively to ferrous
heme-iron [26–30]. The latter gases were considered for years to
be toxic molecules based on their competition with oxygen for the
heme-iron. Yet, once it became clear that NO is involved in a
variety of metabolic signaling pathways, its recognition as a
physiological regulator in vascular and other organ functions
became established [28,31].
In recent years the essential role of CO, the product of heme
catabolism by the enzyme Heme Oxygenase (HO, specifically its
inducible form, HO-1) has been clarified [32–35]. While it is
obvious that HO’s protective function relates to heme clearance,
this enzyme was reported also to be involved directly and
indirectly in a variety of central protective physiologic mecha-
nisms, many of which are mediated by its product, CO [29,30,36–
38]. Specifically, progression of atherosclerosis is effectively
inhibited by upregulation of HO-1/CO [39]. The specific high
affinity of CO for ferrous iron calls for its broad optional
involvement in hemoproteins reduction. Indeed, previous studies
have indicated CO-driven ferric heme reduction. One such
reduction mechanism is built-in as in the enzyme cytochrome C
oxidase, where existence of copper in porphyrin aids electron
transfer, as the enzyme function is to reduce oxygen [40,41]. In
contrast, in the case of a respiratory protein like hemoglobin,
which lacks built-in electron transfer assistance, an external
reducing agent is required. We hypothesized that under in vivo
conditions peroxides in low concentration can assist the reduction
in presence of CO.
The present study was designed to analyze in vitro on a
molecular level, whether the potential dangerous oxidative
activities of acellular RH and peroxides can be attenuated by
the HO product, CO. To mimic in vivo plasma conditions,
reactions were carried out in an anaerobic environment using
ferric RH and peroxides at their concentration levels reported
under a variety of pathological circumstances. It was found that in
the presence of CO damaging peroxides are consumed while ferric
RH are transformed into their nonhazardous carboxy-forms.
Results
Effect of CO on the interaction of hydrophilic (H2O2)
peroxides with ferric hemoproteins
The first part of the study was designed to test whether CO can
affect the interaction between metHb (Fe
III) and H2O2. To mimic
in vivo conditions of restricted free oxygen (under physiological
condition, practically all oxygen is hemoglobin bound) the
reactions were carried out under oxygen-free conditions in a CO
atmosphere which resulted in a CO concentration of 1 mM in
water phase [42,43]. Hb and H2O2 were used at a concentration
range of few micromolars throughout the study. Control reactions
were carried out under neutral gases, argon or nitrogen, without
CO or in a CO atmosphere in which no peroxides were added.
The data in Figure 1A indicate that within two hours significant
spectral changes occurred in the experimental mixture: red shift of
the Soret (c, 405–440 nm) band and the formation of two new
prominent peaks in the visible region bands (a, ,570 nm and b,
,540 nm). The newly formed spectrum (Fig. 1A, bold line)
resembles that of the well characterized carboxyHb (COHb, Soret
peak at 419 nm, a band at 569 and b band at ,540 nm) [44]. In
contrast, in control mixtures lacking either CO or H2O2
practically no changes occurred in the spectra pattern and only
minor changes in the optical density (OD) were detected (Fig. 1B
& C). Similar results were observed by replacing Hb by Mb (data
not shown).
The spectral changes are easier noticeable when presented as
difference spectra depicted in Figure 1D. The minimal alterations
in the absence of CO (line c) result from ferryl formation and
hemin oxidative disintegrations by H2O2 as discussed in the
literature [2,3]. In absence of H2O2 (line b) spectral changes, due
to the reduction of metHb under CO atmosphere lacking a
reducing agent, have already been described, however they are
extremely slow (t1/2 of ,50 days) [45].
Figure 1. Effect of CO atmosphere on the interaction of H2O2
with ferric Hb. Light absorption spectra of the reaction mixtures at
time zero (narrow lines) and following two hours of incubation (heavy
lines) are depicted. A – experimental mixture containing ferric Hb and
H202 under CO atmosphere (,1 mM in water phase); B – control
reaction mixture without H2O2; C – control reaction mixture in which
CO atmosphere was replaced by inert gas; D – difference spectra (DOD)
of time zero and following 2 hours of A, B and C (marked by small
letters a, b and c). Note scale differences of Soret and visible regions.
doi:10.1371/journal.pone.0033039.g001
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Mb (Fig. 2) at wavelengths of carboxy b bands (,540 nm)
indicated that all H2O2-induced alterations were completed within
two hours. The kinetic patterns of the CO lacking controls of both
hemoproteins exhibited an initially fast absorption increase,
followed by a decreasing phase (Fig. 2, lines c). Such a pattern is
typical of ferryl (Fe
IV) formation followed by its auto-reduction to
ferric (Fe
III) forms [45]. In peroxide lacking controls only moderate
increases in absorption could be observed (Fig. 2, lines b) which
correlated with Figure 1 B &D (line b) data and previous literature
[45]. In contrast, in the experimental reaction mixtures, only
increased absorption occurred (Fig. 2, lines a). These kinetic
patterns provide additional evidence that in the presence of CO,
the stable carboxy-hemoproteins, rather than the unstable ferryl
forms, were produced. Consistent with the above conclusion,
addition of sodium sulfide (Na2S) two hours after reaction
initiation did not result in any formation of the typical ferryl
product (data not shown) [46]. Using DOD of the a band
(,570 nm, Fig. 1A) and the related extinction coefficient, the
amount of COHb formed was estimated at least 50% of initial Hb
content despite partial heme disintegration [47]. To eliminate
hemin disintegration and significant peroxidase-like contribution,
in the next experiment concentrations of H2O2 used were equal or
lower then those of Hb.
The results demonstrated in Figure 3 indicate that the rates of
metHb reduction and COHb formation as well as final amount of
COHb produced within 2 hours are H2O2 concentration
dependent.
The experiments up to this stage were performed in solutions
equilibrated with an atmosphere containing CO alone which, as
stated, yield about 1 mM of the gas in the liquid phase. Such a
concentration is not expected to be formed in the plasma even
following long-term activated HO-1. Therefore the following
experiment tested whether H2O2 can be effective as a ferric Hb
reducing agent in the presence of lower CO concentrations. Free
oxygen was also avoided in this experiment by using a neutral gas
(nitrogen) as a complement. As slower reaction rates are expected
by lowering one of reactant concentrations, the reaction mixtures
were incubated overnight (ON). Figure 4 depicts difference
absorption spectra following the incubation period. As can be
seen, at lower CO concentrations ferric to carboxyHb transfor-
mation occurred as well.
Figure 2. Effect of CO on time dependent patterns of
carboxyRH forms b band (,540 nm). The ‘‘a’’ curves in each panel
depict experimental mixtures containing ferric Hb (upper panel) or Mb
(lower panel) and H202 in CO atmosphere. The ‘‘b’’ curves in each panel
depict controls lacking H2O2. The ‘‘c’’ curves in each panel depict
controls in which the CO atmosphere was replaced by an inert gas.
(Time zero=,1 min following mixing.).
doi:10.1371/journal.pone.0033039.g002
Figure 3. Dependence of carboxyHb formation rate on H2O2
concentration. Shown are the b band (537 nm) time dependent
patterns of experimental mixtures containing ferric Hb in CO
atmosphere following an addition of H202 in concentrations of: 10 mM
- curve 1, 5 mM - curve 2, 2.5 mM - curve 3.
doi:10.1371/journal.pone.0033039.g003
Figure 4. Interaction of low CO concentration with H2O2/ferric
Hb. Reaction mixtures contained ferric Hb, H2O2 and differing
concentrations of CO in the experimental environment. Difference
spectra of time zero and ON incubation after subtraction of CO lacking
control are presented. Curve 1 – 1 mM CO in reaction mixture (100% CO
in atmosphere); Curve 2 - 0.2 mM CO in reaction mixture (CO 20%/N2
80% in atmosphere); Curve 3 – 0.05 mM Co (CO5%/N2 95% in
atmosphere). Note scale differences of Soret and visible regions.
doi:10.1371/journal.pone.0033039.g004
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peroxides with ferric hemoproteins
To analyze a possible interaction of hydrophobic peroxides and
metHb, oxidized LDL (oxLDL) formed by copper were used
initially [48]. The experimental mixture containing ferric Hb and
oxLDL was incubated under CO atmosphere. For this reaction,
two types of controls were applied: the same mixture incubated
under neutral gas (argon) or replacement of oxLDL by fresh,
native, peroxide-poor LDL (nLDL). Figure 5 illustrates the original
and difference spectra of the experimental and control mixtures
following ON incubation. Comparison of the samples kept under
CO (line 1) and inert gas (argon, line 2) indicates clear differences:
in the reaction mixture incubated under inert gas, the increase in
OD is strictly a result of light scatter, since no red shift of the Soret
(c) band, nor formation of new peaks in the visible region bands
were observed. In contrast, the absorption spectrum of the sample
incubated under CO demonstrates two new spectral features: (a)
formation of peaks in the visible spectrum; (b) formation of a
doublet Soret peak. The double Soret peak results from part of the
hemoprotein shifting to the red. The difference spectrum of 1&2
(Fig. 5B) resembles a typical COHb spectrum and hence indicates
the formation of this adduct. It is well documented that ferric Hb
causes LDL oxidation followed by apoB protein cross-linking
which produces light scattering aggregates [7,15,48,49]. Thus, the
high light scatter observed under the inert gas (Fig. 5A, line 2)
points to increased LDL oxidation in this sample as compared to
the reaction under CO atmosphere (Fig. 5A, line 1). Regarding the
nLDL control (Fig. 5A, line 3), some COHb is formed as well,
probably by the involvement of low level peroxides existing even in
fresh LDL [50]. On the other hand, the difference absorption
spectrum in Figure 5C clearly indicates that when LDL is loaded
with peroxides (oxLDL), more COHb is formed. Moreover, the
Soret double peak (405 & 419 nm) in the difference spectrum
indicates, that the oxLDL sample contains a higher level of
residual ferric Hb.
Having demonstrated that the copper oxidized LDL model can
replace hydrophilic peroxides as reducing agents for metHb in
presence of CO, it was of importance to study the activity of
‘‘naturally’’ oxidized aged LDL which can form in vivo [48]. Aged
LDL was produced from a freshly isolated sample by long term
incubation (see methods) [51]. To evaluate whether aged LDL
contained a higher level of peroxides, their oxidizing potential was
compared to that of fresh LDL from the same donor by standard
parameters, oxidation lag time and level of conjugated dienes [52].
To measure the oxidation lag time, a minor amount of free hemin
was used (see methods section). While fresh LDL had a lag time of
about two hours, aged LDL had practically zero lag time (Fig. 6A).
In addition, aged LDL, as compared to fresh one, demonstrated
increased absorption at 234 nm indicating extra conjugated dienes
(Fig. 6B).
Once the increased oxidability of aged LDL was demonstrated,
it was further employed as a source of hydrophobic peroxides to
determine whether they are able to act as reducers of ferric RH in
presence of CO. Experimental mixtures containing ferric Hb or
Mb and aged LDL were incubated under CO atmosphere. LDL
lacking mixtures were used as controls. The difference spectra of
time zero and ON incubation are depicted in Figure 7. The results
revealed that although negligible amounts of carboxyRH formed
in the LDL lacking controls, a considerably increased amount of
COHb/Mb formed in the aged LDL containing reaction
mixtures. These data clearly indicate that lipid peroxides react
similarly to H2O2 as ferric heme-iron reducing agents and trap the
RH in their carboxy, inactive forms.
Discussion
The focus of the current study was to highlight the potential
involvement of the HO-1, specifically its product CO, in limiting
vascular oxidative stress mediated by cell-free RH. Our data
showed that the combined presence of H2O2 and CO resulted in
transformation of ferric RH into their carboxy forms (Fig. 1, 2, 3,
4). These results clearly showed the reduction of ferric heme-iron
in the RH to ferrous state. The only source of reducing equivalents
in this experimental system is the participating peroxide. Despite
the weak reducing activity of peroxide, the fast and practically
irreversible reaction of ferrous heme-iron with CO resulted in a
shift of the equilibrium towards the carboxy forms of RH [53].
The two reaction steps and their relative rates based on the
literature are summarized below:
I) H2O2+RH(Fe
III)RRH(Fe
II)+KO2+H2O (very slow)
Figure 5. Effect of CO on the interaction of ferric Hb with
copper oxidized LDL. A - Spectra of reaction mixtures incubated ON:
Curve 1 - experimental mixture containing ferric Hb, oxLDL and 1 mM
CO; Curve 2 – control in which CO was replaced by inert gas in the
experimental environment; Curve 3 - control in which oxLDL was
replaced by nLDL. Note scale differences of Soret and visible regions. B -
Difference spectrum of curves 1 & 2 in A. C - Difference spectrum of
curves 1 & 3 in A.
doi:10.1371/journal.pone.0033039.g005
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II)+CORCORH(Fe
II) (fast)
As can be seen, the products of reaction I are molecular oxygen
and water, obviously physiologically harmless components.
CarboxyRH, the product of reaction II, is extremely stable, thus
redox inactive. It appears therefore that the main impact of CO is
not reduction of ferric heme-iron per se, but rather its arrest in the
ferrous carboxy complex, a practically irreversible process.
Equilibrium is then shifted via Le Chatelier’s principle. Therefore,
the net result of the reaction appears to be replacement of
injurious plasma components, metRH and H2O2, by physiolog-
ical, harmless, metabolites.
The link between oxidative conditions, elevated peroxides
(hydrophilic and hydrophobic) and Hb in vascular pathology is
well established [54]. Also both metHb and peroxides, readily
formed under oxidative conditions, were proven to be inducers of
HO-1 [55,56]. The combined results establish the protecting role
of HO-1 and its products as antagonists of both peroxide and
heme-iron oxidative reactivity. These pathways are schematically
illustrated in Figure 8.
It is important to note that other electron donors can affect
ferric RH in a similar manner. For example, in presence of CO
the reduction of ferric to ferrous Mb occurs in a mutant protein
where a correctly positioned cysteine residue is responsible for
electron transfer to the heme-iron [57]. Moreover, the combined
effect of HO/CO system and peroxides to achieve the double
purpose redox neutralization of damaging both peroxides and
metalloproteins in the living kingdom is even beyond animal
space. Several studies indicated that elevated HO or CO in plants
result in decreased peroxides levels and lipid peroxidation [58].
Epidemiological studies evaluating metHb and COHb levels
usually refer to total blood containing mostly encapsulated Hb.
Since cell-free Hb is a minor part of total Hb, changes in this
fraction are usually not observed. Interestingly, support for our in
vitro data could be found from in vivo total hemoglobin evaluation
following abdominal surgery [59]. Measurements were performed
immediately post-operation and one day later. Although mea-
surements were carried out in whole blood, careful examination of
the results ([59] table 5) indicates that parallel increased COHb
and decreased metHb were found only in those patients who did
not receive blood transfusion one day after the operation which
possibly reflect on much larger differences in cell-free in plasma
Hb.
It should be noted that diminished oxidability of RH by CO
using any electron source, even a weak one like peroxides,
probably represents a much broader phenomena than that shown
in the current study for the RH and peroxides. Horseradish
Peroxidase (HRP) is a classic heme-enzyme with a ferric ground
state is also reduced to ferrous iron thereby binding CO with high
affinity [60]. HRP efficiently uses peroxides to oxidize diverse
substrates including LDL. It appears that ferric-HRP can be
reduced by LDL peroxides and thus arrested in a CO bound
ferrous state [50]. The difference between a classic hemo-
peroxidase and pseudo RH peroxidases is that while the ferric
state of the classic enzyme is stable, that of RH specifically Hb, can
Figure 6. Increased peroxidation in aged LDL. A - Oxidation by
hemin (1 mM) presented as derivatives of time course (l268 nm),
indicating formation of conjugated dienes. Heavy line – aged LDL,
narrow line – fresh LDL. B - Increased content of conjugated dienes in
aged LDL presented as difference spectrum of aged and fresh LDL.
doi:10.1371/journal.pone.0033039.g006
Figure 7. Effect of CO on the interaction of ferric RH with
hydrophobic peroxides in aged LDL. Difference absorption spectra
of time zero and ON incubated reaction mixtures containing ferric Hb
(upper panel) or Mb (lower panel), aged LDL and 1 mM CO are shown.
The spectrum of the LDL lacking control was subtracted from both
reaction mixtures spectra. Note scale differences of Soret and visible
regions.
doi:10.1371/journal.pone.0033039.g007
Figure 8. Schematic view of HO-1/CO protection mechanism.
Left side: Damage induced by peroxides and peroxidase-like activity of
ferric RH Right side: HO-1/CO shield provided by shifting the peroxide
oxidation towards reduction thereby producing redox-inactive ferrous
carboxyRH.
doi:10.1371/journal.pone.0033039.g008
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reaching oxidation takes place [15]. However shutting down any
electron transfer from the heme iron by CO will arrest both
pathways.
An additional aspect related to the consequences of the present
study involves iron chelators. These molecules, originally designed
to strongly bind hazardous free iron and eliminate it from plasma,
were recently demonstrated to function as antioxidants as well. By
binding to ferric heme-iron, the chelators prevent also oxidative
modifications [61]. In the presence of CO, the oxidation is actually
prevented by a similar mechanism, only that in this case the heme-
iron is trapped in its ferrous state.
As stated, the current in vitro study specifically used both
hemoproteins and peroxides concentration range to mimic in vivo
plasma conditions which ensue during acute or chronic vascular
hemolysis.At thisstateofaffairs,RHperoxidase-like activity,namely
heme iron redox-shuttle (Fe
III«Fe
IV), is limited and damage may
result mostly from unstable hemin RH met-forms [6,62].
The current study data indicate that metRH can be reduced to
the more stable ferrous states with aid of endogenously HO-
produced CO. The latter process (Fe
IIIRFe
II) is analogous to the
on going course of action provided to circulating Hb captured
within red cells. Howether at more extreme pathological
conditions the unstable hemin in ferric RH may be trapped by
hemopexin [19]. It is only then hemopexin is exhausted and
hemin leaks into LDL particles leading to irreversible damage [7].
It is well known in clinical biochemistry that an elevated COHb
level is a marker for oxidative pathological processes such as in the
case of hemolytic events [63,64]. This elevation has been related to
replacing oxygen in oxyHb with CO produced by induced HO.
Our data support an as yet unrecognized medical benefit of
carboxy hemoproteins formation, increasing vascular defense by
CO-induced arrest of ferric Hb and elimination of peroxides.
Materials and Methods
All participants provided informed, written consent; ethical
approval for this study was obtained through the research ethics
board of Tel-Aviv University.
Materials
Myoglobin (equine), Hemin (from bovine red cells), Albumin
(bovine serum, BSA), ethylene diamine tetraacetic acid (EDTA)
and phenylmethylsulfonyl fluoride (PMSF) were purchased from
Sigma-Aldrich, Israel. Hydrogen peroxide (H2O2) and potassium
bromide (KBr) was from Merck, Darmstadt, Germany. PD-10
desalting columns were purchased from GE Healthcare UK Ltd.
CM-52 and DE-52 celluloses were obtained from Whatman
International, Maidstone, England. Ferricyanide was from Agan
Chemical Manufacturers Ltd., Israel. Gases: Carbon monoxide
(CO), at least 99.5%, was supplied by Gordon Gas and Chemicals
Ltd., Israel; Nitrogen (N2, 99.9%) and Argon (Ar, 99.5%) were
supplied by Israel Oxygen Centre.
Hemoglobin isolation from fresh blood
Hemoglobin was purified from fresh human red blood cell lysates
by ion-exchange chromatography using CM-52 cellulose followed
by desalting dialysis. Since H2O2 was used in some reaction
mixtures, Hb preparations were checked for lack of catalase by
ferryl Hb formation in the presence of an equimolar amount of
H2O2. Purified Hb was verified spectrophotometrically as oxyHb.
MetHb was prepared from the oxyHb by oxidation with
ferricyanide [65]. The reagent was removed usind PD-10 desalting
column and globin-free hemin contaminants were removed by
admixing the metHb solution with DE-52 cellulose [66]. Concen-
trations of all hemoproteins were measured spectrophotometrically
and expressed in heme equivalents throughout this study.
Low density lipoprotein (LDL) isolation
LDL was isolated from fresh human plasma (EDTA anticoag-
ulated) of healthy donors by sequential ultracentrifugation as
described [67], using Beckman Optima LE-80K ultracentrifuge
(rotor Ti-70.1, 47,000 RPM). The obtained solution was passed
through two sequential PD-10 columns to remove EDTA and
other small molecules. LDL concentration was determined by the
Lowry method using BSA as a standard and expressed as mg
protein/ml [68].
Oxidized LDL (oxLDL) preparation
Freshly isolated LDL was oxidized by copper according to the
literature with some modifications [69]. Briefly, freshly prepared
LDL (2–3 mg protein/ml) was incubated in the presence of
CuSO4 (five fold molar protein concentration) for 2 hours in 37uC
and immediately passed through two PD-10 columns.
Aged LDL preparation
Freshly isolated LDL was sterilized by passing through 0.2 mM
filters and further incubated for at least 10 weeks in 4uC [51]. Two
standard parameters were used to determine LDL oxidation,
conjugated diens and oxidation lag time. Conjugated dienes with
the typical absorption maximum at 234 nm are used as a routine
to follow LDL oxidation [52]. To follow the oxidation lag time
1 mM of hemin was used (stock solution was prepared in DMSO
80%). In the current study, as in previous, we used 268 nm as the
undesired light scatter contribution is sharply reduced with
decreased wavelength [15].
Spectrophotometry
Spectral characteristics and time dependent changes spectral in
reaction mixtures were monitored by single or repetitive (every
135 sec) scanning of light absorbance spectra at UV and/or visible
wavelength range using a Contron – UVIKONXL or thermostated
GBC UV/VIS 920 spectrophotometer.
Reactions conditions
All reactions were carried out in PBS pH 7.4 at 37uC. The
appropriate gas atmosphere was reached as follows: the desired gas
was bubbled into the media solutions in rubber septa sealed
spectrophotometric cuvettes. Protein containing stock solutions
were equilibrated a priori by the desired or nitrogen as neutral gas
and were further diluted (by injection) into cuvettes up to 5% of
volume. Under such conditions the gases concentration in the
liquid phase reaches about 1 mM [43].
The following reactants were used at constant concentrations:
hemoproteins - 10 mM, H2O2 -3 0mM (1: 250 dilution of stock),
LDL - 100 mg protein/ml.
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